Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.
Early and sustained antiretroviral treatment could help reduce the risk.
An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.
Declining rates are expected for Kaposi sarcoma, non–Hodgkin lymphoma, cervical and lung cancer and Hodgkin lymphoma, among others.
This held true in a recent study among those who were on treatment for the virus.
However, older people with HIV have a lower rate of a few other cancers compared with the general population.
However, compared with the general population, HIV-positive individuals remain at higher risk for a slew of malignancies.
With the HIV population aging, it is increasingly at risk of such age-related cancers.
A recent study found that from 1995 to 2009, 10 percent of all deaths among a large cohort of people on HIV treatment were cancer-related.
The increased risk of some virus-associated cancers, such as non–Hodgkin lymphoma, did not appear driven by increased sexual risk taking.
As AIDS-related cancers decline and the HIV population ages, the most common malignancies by 2030 will likely be those related to aging.
Having either form of viral hepatitis was associated with about a 75 percent increased risk of non–Hodgkin lymphoma in a recent study.
For HIV-positive people who develop non-Hodgkin’s lymphoma including the drug Rituxan with standard chemo increases chances of survival.
For people diagnosed with AIDS-related lymphomas, adding Rituxan to standard chemotherapy has a major positive effect on survival
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.